Skip to content
Reipet – Lifestyle
Author:
AbelZeta Pharma, Inc.
AbelZeta announces publication in Nature journal highlighting clinical findings for an armored autologous GPC3 CAR-T therapy in patients with advanced hepatocellular carcinoma
July 23, 2026
AbelZeta Receives EMA PRIME Designation for C-CAR168 in Lupus Nephritis and Systemic Lupus Erythematosus
July 20, 2026